pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling*
暂无分享,去创建一个
[1] G. Núñez,et al. Clathrin- and Dynamin-Dependent Endocytic Pathway Regulates Muramyl Dipeptide Internalization and NOD2 Activation1 , 2009, The Journal of Immunology.
[2] Praveen M. Bahadduri,et al. Bacterial peptide recognition and immune activation facilitated by human peptide transporter PEPT2. , 2008, American journal of respiratory cell and molecular biology.
[3] D. Philpott,et al. The microbial and danger signals that activate Nod-like receptors. , 2008, Cytokine.
[4] S. Akira,et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.
[5] S. Girardin,et al. Nod1 and Nod2 in innate immunity and human inflammatory disorders. , 2007, Biochemical Society transactions.
[6] S. Grinstein,et al. Phagosomal acidification: measurement, manipulation and functional consequences. , 2007, Biochemical Society transactions.
[7] D. Portnoy,et al. Bacterial Ligands Generated in a Phagosome Are Targets of the Cytosolic Innate Immune System , 2007, PLoS pathogens.
[8] D. Philpott,et al. Nod-like proteins in immunity, inflammation and disease , 2006, Nature Immunology.
[9] M. Brandsch,et al. The renal type H+/peptide symporter PEPT2: structure-affinity relationships , 2006, Amino Acids.
[10] M. Kaksonen,et al. Harnessing actin dynamics for clathrin-mediated endocytosis , 2006, Nature Reviews Molecular Cell Biology.
[11] T. Kirchhausen,et al. Dynasore, a cell-permeable inhibitor of dynamin. , 2006, Developmental cell.
[12] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[13] E. Latz,et al. Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity , 2006, The EMBO journal.
[14] J. Bertin,et al. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin , 2005, EMBO reports.
[15] D. Russell,et al. Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. , 2005, Immunity.
[16] R. Xavier,et al. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor–κB activation in muramyl dipeptide recognition , 2005, The Journal of cell biology.
[17] Y. Nakagawa,et al. hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. , 2004, Gastroenterology.
[18] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[19] R. Medzhitov,et al. Regulation of Phagosome Maturation by Signals from Toll-Like Receptors , 2004, Science.
[20] T. Hartung,et al. Structural Requirements of Synthetic Muropeptides to Synergize with Lipopolysaccharide in Cytokine Induction* , 2004, Journal of Biological Chemistry.
[21] H. Daniel,et al. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology , 2004, Pflügers Archiv.
[22] B. Monks,et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.
[23] D. Philpott,et al. Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2* , 2003, Journal of Biological Chemistry.
[24] S. Foster,et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.
[25] J. Bertin,et al. Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan , 2003, Science.
[26] P. Rosenstiel,et al. TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢ , 2003 .
[27] M. Chamaillard,et al. Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.
[28] S. Foster,et al. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.
[29] Yasunori Ogura,et al. Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation* , 2002, The Journal of Biological Chemistry.
[30] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[31] Judy H. Cho,et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.
[32] D. Markovich,et al. Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Romero,et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter , 1994, Nature.
[34] N. Phillips,et al. Tumor Cell Binding and Induction of Endothelial Cell Tumoricidal Activity In Vitro by Muramyl Dipeptide Is Enhanced by Liposomal Encapsulation , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[35] E. Lederer. Synthetic immunostimulants derived from the bacterial cell wall. , 1980, Journal of medicinal chemistry.
[36] S. Kusumoto,et al. Macrophage activation by bacterial cell walls and related synthetic compounds , 1979, Infection and immunity.
[37] M. Kaksonen,et al. Cytoskeletal networks and pathways involved in endocytosis. , 2005, Novartis Foundation symposium.
[38] I. Fidler,et al. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes. , 1987, International journal of immunopharmacology.
[39] I. Fidler,et al. Liposome encapsulation of muramyl peptides for activation of macrophage cytotoxic properties. , 1986, Methods in enzymology.
[40] E. Lederer. New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines. , 1986, Drugs under experimental and clinical research.
[41] I. Fidler,et al. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. , 1982, Cancer research.